412 related articles for article (PubMed ID: 8955053)
1. Kinetics of duck hepatitis B virus infection following low dose virus inoculation: one virus DNA genome is infectious in neonatal ducks.
Jilbert AR; Miller DS; Scougall CA; Turnbull H; Burrell CJ
Virology; 1996 Dec; 226(2):338-45. PubMed ID: 8955053
[TBL] [Abstract][Full Text] [Related]
2. Antiviral therapy with entecavir combined with post-exposure "prime-boost" vaccination eliminates duck hepatitis B virus-infected hepatocytes and prevents the development of persistent infection.
Miller DS; Boyle D; Feng F; Reaiche GY; Kotlarski I; Colonno R; Jilbert AR
Virology; 2008 Apr; 373(2):329-41. PubMed ID: 18206204
[TBL] [Abstract][Full Text] [Related]
3. Viral load in 1-day-old ducklings acutely infected with duck hepatitis B virus by different doses and routes of inoculation.
Chen ZY; Cheng AC; Wang MS; Xu DW; Jia R; Guo YF; Zeng W
Avian Pathol; 2009 Apr; 38(2):129-34. PubMed ID: 19322711
[TBL] [Abstract][Full Text] [Related]
4. Vaccination of ducks with a whole-cell vaccine expressing duck hepatitis B virus core antigen elicits antiviral immune responses that enable rapid resolution of de novo infection.
Miller DS; Halpern M; Kotlarski I; Jilbert AR
Virology; 2006 May; 348(2):297-308. PubMed ID: 16469347
[TBL] [Abstract][Full Text] [Related]
5. Covalently closed circular DNA is the predominant form of duck hepatitis B virus DNA that persists following transient infection.
Le Mire MF; Miller DS; Foster WK; Burrell CJ; Jilbert AR
J Virol; 2005 Oct; 79(19):12242-52. PubMed ID: 16160150
[TBL] [Abstract][Full Text] [Related]
6. DNA vaccines expressing the duck hepatitis B virus surface proteins lead to reduced numbers of infected hepatocytes and protect ducks against the development of chronic infection in a virus dose-dependent manner.
Miller DS; Kotlarski I; Jilbert AR
Virology; 2006 Jul; 351(1):159-69. PubMed ID: 16624364
[TBL] [Abstract][Full Text] [Related]
7. Characterization of age- and dose-related outcomes of duck hepatitis B virus infection.
Jilbert AR; Botten JA; Miller DS; Bertram EM; Hall PM; Kotlarski J; Burrell CJ
Virology; 1998 May; 244(2):273-82. PubMed ID: 9601498
[TBL] [Abstract][Full Text] [Related]
8. Antiviral effects of PNA in duck hepatitis B virus infection model.
Chen ZY; Cheng AC; Wang MS; Xu DW; Zeng W; Li Z
Acta Pharmacol Sin; 2007 Oct; 28(10):1652-8. PubMed ID: 17883953
[TBL] [Abstract][Full Text] [Related]
9. The persistence in the liver of residual duck hepatitis B virus covalently closed circular DNA is not dependent upon new viral DNA synthesis.
Reaiche GY; Le Mire MF; Mason WS; Jilbert AR
Virology; 2010 Oct; 406(2):286-92. PubMed ID: 20705309
[TBL] [Abstract][Full Text] [Related]
10. Acute liver injury following infection with a cytopathic strain of duck hepatitis B virus.
Lenhoff RJ; Luscombe CA; Summers J
Hepatology; 1999 Feb; 29(2):563-71. PubMed ID: 9918936
[TBL] [Abstract][Full Text] [Related]
11. The early host innate immune response to duck hepatitis B virus infection.
Tohidi-Esfahani R; Vickery K; Cossart Y
J Gen Virol; 2010 Feb; 91(Pt 2):509-20. PubMed ID: 19846670
[TBL] [Abstract][Full Text] [Related]
12. Alternative methods for validation of cell culture infection with duck hepatitis B virus.
Sauerbrei A; Schacke M; Schultz U; Egerer R; Merkle I; Glebe D; Gerlich W; Wutzler P
J Virol Methods; 2005 Nov; 129(2):178-85. PubMed ID: 16002155
[TBL] [Abstract][Full Text] [Related]
13. Electron microscopic studies on duck hepatitis B virus particles in hepatocytes and sequential changes in various patterns of infection.
Okinaga S; Fukuda R; Fukumoto S; Shimada Y
Gastroenterol Jpn; 1991 Aug; 26(4):458-64. PubMed ID: 1916154
[TBL] [Abstract][Full Text] [Related]
14. Hepatic neoplasms in aflatoxin B1-treated, congenital duck hepatitis B virus-infected, and virus-free pekin ducks.
Cullen JM; Marion PL; Sherman GJ; Hong X; Newbold JE
Cancer Res; 1990 Jul; 50(13):4072-80. PubMed ID: 1972346
[TBL] [Abstract][Full Text] [Related]
15. Competition in vivo between a cytopathic variant and a wild-type duck hepatitis B virus.
Lenhoff RJ; Luscombe CA; Summers J
Virology; 1998 Nov; 251(1):85-95. PubMed ID: 9813205
[TBL] [Abstract][Full Text] [Related]
16. Contribution of aflatoxin B1 and hepatitis B virus infection in the induction of liver tumors in ducks.
Cova L; Wild CP; Mehrotra R; Turusov V; Shirai T; Lambert V; Jacquet C; Tomatis L; Trépo C; Montesano R
Cancer Res; 1990 Apr; 50(7):2156-63. PubMed ID: 2107970
[TBL] [Abstract][Full Text] [Related]
17. [Establishment of an in vivo model for duck hepatitis B virus infection using Hubei duckling].
Hu Q; Fang Y; Zhang ZM; Zhang XY; Zhang ZH; Yang DL
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Apr; 22(2):113-5. PubMed ID: 18574531
[TBL] [Abstract][Full Text] [Related]
18. The half-life of duck hepatitis B virus supercoiled DNA in congenitally infected primary hepatocyte cultures.
Civitico GM; Locarnini SA
Virology; 1994 Aug; 203(1):81-9. PubMed ID: 8030288
[TBL] [Abstract][Full Text] [Related]
19. [Study on the replication of hepatitis B virus compared with that of duck hepatitis B virus in primary duck hepatocytes].
Yao Y; Tang N; Huang A
Zhonghua Yi Xue Za Zhi; 2001 Oct; 81(19):1157-61. PubMed ID: 11769700
[TBL] [Abstract][Full Text] [Related]
20. [Anti-virus effect of hepatocyte stimulating substance (HSS) on duck hepatitis B virus in vivo].
Chen G; Chen J; Liu D; Zhang X; Zhu C; Li Y; Wang L; Yang Y; Cai G; Han F
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Dec; 11(4):329-32. PubMed ID: 15617240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]